Effect of (Z)-isomer content on [11C]ABP688 binding potential in humans
- PMID: 30607444
- DOI: 10.1007/s00259-018-4237-3
Effect of (Z)-isomer content on [11C]ABP688 binding potential in humans
Abstract
Purpose: To determine how the low-affinity (Z)-isomer of the radiotracer [11C]ABP688 affects binding potential values in vivo in humans.
Methods: High-resolution [11C]ABP688 PET scans were acquired on 74 healthy volunteers (25 male, 49 female, mean age 20 ± 3.0). The relative contents of (E)- and (Z)-isomers were determined prior to injection using analytical high-performance liquid chromatography [rt(E) = 10 min, rt(Z) = 8.5 min]. Mean binding potential [BPND = fND * (Bavail/KD)] values were calculated in the striatum, limbic regions, and prefrontal cortex using the simplified reference tissue model with cerebellar grey matter as reference.
Results: Mean ± SD (E)-isomer content in [11C]ABP688 production was 92 ± 3.8% (range 78-97%). Percent (E)-isomer was positively correlated with BPND in the striatum (ρ = 0.28, p = 0.015) and limbic regions (ρ = 0.25, p = 0.036). In multiple regression analysis, sex (β = 0.39, p = 0.001) and (E)-isomer content (β = 0.23, p = 0.040) were significant predictors of BPND.
Conclusions: Even modest levels of (Z)-[11C]ABP688 can reduce estimates of tracer binding in vivo. Future studies should use production methods that enrich levels of (E)-[11C]ABP688, report tracer isomer ratios, and account for this factor in their analyses.
Keywords: Metabotropic glutamate receptors; PET; Positron emission tomography; [11C]ABP688; mGluR5.
References
MeSH terms
Substances
Grants and funding
- MOP119509/Canadian Institutes of Health Research/Canada
- MOP133537/Canadian Institutes of Health Research/Canada
- 97910/Canadian Institutes of Health Research/Canada
- 981055 and 991027/Fonds de Recherche du Québec - Santé (CA)
- 839-2000-1008 and 410-99-1048/Social Sciences and Humanities Research Council of Canada
LinkOut - more resources
Full Text Sources
